5-carboxamidotryptamine has been researched along with aripiprazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Altamura, C; Arzuaga, A; Ciranna, L; Costa, L; Desaphy, JF; Lacivita, E; Leopoldo, M; Niso, M; Ragozzino, ME; Stama, ML | 1 |
1 review(s) available for 5-carboxamidotryptamine and aripiprazole
| Article | Year |
|---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
1 other study(ies) available for 5-carboxamidotryptamine and aripiprazole
| Article | Year |
|---|---|
Privileged scaffold-based design to identify a novel drug-like 5-HT
Topics: Dose-Response Relationship, Drug; Drug Design; Fragile X Syndrome; HEK293 Cells; Humans; Molecular Structure; Piperazines; Receptors, Serotonin; Serotonin Receptor Agonists; Structure-Activity Relationship | 2020 |